Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

AMPLATZER Duct Occluder II Clinical Study

Study:

Closure of Patent Ductus Arteriosus With the AMPLATZER DUCT Occluder II

Rationale:

n/a

Purpose:

The objective of this study is to investigate the safety and effectiveness of the ADO II in patients with a PDA.

Study Status: Active, not recruiting

Recruiting:
n/a

Condition Intervention Phase
Patent Ductus Arteriosus Device: AMPLATZER Duct Occluder II N/A

Verified by AGA Medical Corporation October, 2013

Sponsored by: AGA Medical Corporation
Information provided by: AGA Medical Corporation
ClinicalTrials.gov identifier: NCT00713700

Study Type: Interventional

Study Design: Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

The Children`s Hospital at Cleveland Clinic
Cleveland, Ohio 44195
United States

n/a

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.

Cleveland Clinic Mobile Site